Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange wants to conduct 5 pre-IPO transactions in 2024

7/22/24 OTCI

Europlan increased new business volume by 27%

7/22/24 LEAS

Volume of shares traded on the OTC Moscow Exchange exceeded ₽113 billion

7/22/24 MOEX

Yakovlev reported for 6 months of 2024 by RAS

7/22/24 IRKT

APRI has started collecting applications for participation in the IPO

7/22/24 APRI

Severstal reported for 6 months of 2024 by IFRS

7/22/24 CHMF

Board of Directors of Severstal recommended that dividends be paid for 6 months 2024

7/22/24 CHMF

Severstal's sales in the 1st half of the year decreased by 6%

7/22/24 CHMF

Rusagro's revenues in the 1st half of the year increased by 30%

7/22/24 AGRO

Moscow Exchange launched its first Pre-IPO

7/19/24 MOEX